Probability-driven 3D pharmacophore mapping of antimycobacterial potential of hybrid molecules combining phenylcarbamoyloxy and N-arylpiperazine fragments

References

• H.C. Kolb, M.G. Finn, and K.B. Sharpless, Click chemistry: Diverse chemical function from a few good reactions, Angew. Chem. Int. Ed. Engl. 40 (2001), pp. 2004–2021.
   PubMed Web of Science ®Google Scholar
• T.I. Oprea, Property distribution of drug-related chemical databases, J. Comput. Aided Mol. Des. 14 (2000), pp. 251–264.
   PubMed Web of Science ®Google Scholar
• J. Devillers, Methods for building QSARs, Methods Mol. Biol. 930 (2013), pp. 3–27.
   PubMedGoogle Scholar
• R. Gieleciak, T. Magdziarz, A. Bak, and J. Polanski, Modeling robust QSAR. 1. Coding molecules in 3D-QSAR – From a point to surface sectors and molecular volume, J. Chem. Inf. Model. 45 (2005), pp. 1447–1455.
   PubMed Web of Science ®Google Scholar
• R. Todeschini and V. Consonni, Handbook of Molecular Descriptors, Wiley-VCH Verlag, Weinheim, 2000.
   Google Scholar
• I.V. Tetko and T.I Oprea, Early ADME/T predictions: Toy or tool? in Chemoinformatics Approaches to Virtual Screening, A. Varnek, and A. Tropsha, eds., Royal Society of Chemistry, Cambridge, 2008, pp. 240–267.
   Google Scholar
• H. van de Waterbeemd and E. Gifford, ADMET in silico modeling: Towards prediction paradise? Nat. Rev. Drug Discov. 2 (2003), pp. 192–204.
   PubMed Web of Science ®Google Scholar
• H. Kubinyi, Hansch Analysis and Related Approaches, Wiley-VCH Verlag, Weinheim, 1993.
   Google Scholar
• A.K. Ghose, T. Herbertz, J.M. Salvino, and J.P. Mallamo, Knowledge-based chemoinformatic approaches to drug discovery, Drug Discov. Today 11 (2006), pp. 1107–1114.
   PubMed Web of Science ®Google Scholar
• A. Bak, M. Wyszomirski, T. Magdziarz, A. Smoliński, and J. Polanski, Structure-based modeling of dye-fiber affinity with SOM-4D-QSAR paradigm: Application to set of anthraquinone derivatives, Comb. Chem. High Throughput Screen. 17 (2014), pp. 485–502.
   PubMed Web of Science ®Google Scholar
• A. Bak, T. Magdziarz, and J. Polanski, Pharmacophore-based database mining for probing fragmental drug-likeness of diketo acid analogues, SAR QSAR Environ. Res. 3 (2013), pp. 185–204.
   Google Scholar
• J. Polanski, R. Gieleciak, T. Magdziarz, and A. Bak, A. GRID formalism for the comparative molecular surface analysis: Application to the CoMFA benchmark steroids, azo dyes, and HEPT derivatives, J. Chem. Inf. Comput. Sci. 44 (2004), pp. 1423–1435.
   PubMedGoogle Scholar
• J. Polanski, A. Bak, R. Gieleciak, and T. Magdziarz, Self-organizing neural networks for modeling robust 3D and 4D QSAR: Application to dihydrofolate reductase inhibitors, Molecules 9 (2004), pp. 1148–1159.
   PubMed Web of Science ®Google Scholar
• A. Bak, V. Kozik, A. Smolinski, and J. Jampilek, In silico estimation of basic activity-relevant parameters for a set of drug absorption promoters, SAR QSAR Environ. Res. 28 (2017), pp. 427–449.
   PubMed Web of Science ®Google Scholar
• J. Polanski, A. Bak, R. Gieleciak, and T. Magdziarz, Modeling robust QSAR, J. Chem. Inf. Model. 46 (2006), pp. 2310–2318.
   PubMed Web of Science ®Google Scholar
• K. Waisser, K. Drazkova, J. Cizmarik, and J. Kaustova, Antimycobacterial activity of basic ethylesters of alkoxy-substituted phenylcarbamic acids, Folia Microbiol. 48 (2003), pp. 45–50.
   PubMed Web of Science ®Google Scholar
• K. Waisser, K. Drazkova, J. Cizmarik, and J. Kaustova, Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids, Folia Microbiol. 48 (2003), pp. 585–587.
   PubMed Web of Science ®Google Scholar
• K. Waisser, K. Drazkova, J. Cizmarik, and J. Kaustova, A new group of potential antituberculotics: Hydrochlorides of piperidinylalkyl esters of alkoxy-substituted phenylcarbamic acids, Folia Microbiol. 49 (2004), pp. 265–268.
   PubMed Web of Science ®Google Scholar
• C. Hansch and J.M. Clayton, Lipophilic character and biological activity of drugs II. The parabolic case, J. Pharm. Sci. 62 (1973), pp. 1–21.
   PubMed Web of Science ®Google Scholar
• K. Waisser, K. Drazkova, J. Cizmarik, and J. Kaustova, Influence of lipophilicity on the antimycobacterial activity of the hydrochlorides of piperidinylethyl esters of ortho-substituted phenylcarbamic acids, Sci. Pharm. 72 (2004), pp. 43–49.
   Google Scholar
• G. Panda, Shagufta; A.K. Srivastava, and S. Sinha, Synthesis and antitubercular activity of 2-hydroxy-aminoalkyl derivatives of diaryloxy methano phenanthrenes, Bioorg. Med. Chem. Lett. 15 (2005), pp. 5222–5225.
   PubMed Web of Science ®Google Scholar
• R.S. Upadhayaya, G.M. Kulkarni, N.R. Vasireddy, J.K. Vandavasi, S.S. Dixit, V. Sharma, and J. Chattopadhyaya, Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis, Bioorg. Med. Chem. 17 (2009), pp. 4681–4692.
   PubMed Web of Science ®Google Scholar
• R.S. Upadhayaya, J.K. Vandavasi, R.A. Kardile, S.V. Lahore, S.S. Dixit, H.S. Deokar, P.D. Shinde, M.P. Sarman, and J. Chattopadhyaya, Novel quinoline and naphthalene derivatives as potent antimycobacterial agents, Eur. J. Med. Chem. 45 (2010), pp. 1854–1867.
   PubMed Web of Science ®Google Scholar
• A. Bak, V. Kozik, A. Smolinski, and J. Jampilek, Multidimensional (3D/4D-QSAR) probability-guided pharmacophore mapping: Investigation of activity profile for a series of drug absorption promoter, RSC Adv. 6 (2016), pp. 76183–76205.
   Web of Science ®Google Scholar
• H. Kubinyi, QSAR and 3D QSAR in drug design. Part 1: Methodology, Drug Discov. Today 2 (1997), pp. 457–467.
   Web of Science ®Google Scholar
• H. Kubinyi, QSAR and 3D QSAR in drug design. Part 2: Applications and problems, Drug Discov. Today 2 (1997), pp. 538–546.
   Web of Science ®Google Scholar
• J. Zupan and J. Gasteiger, Neural Networks and Drug Design for Chemists. 2nd ed., Wiley-VCH, Weinheim, 1999.
   Google Scholar
• T. Magdziarz, B. Lozowicka, R. Gieleciak, A. Bak, J. Polanski, and Z. Chilmonczyk, 3D QSAR study of hypolipidemic asarones by comparative molecular surface analysis, Bioorg. Med. Chem. 14 (2006), pp. 1630–1643.
   PubMed Web of Science ®Google Scholar
• J. Polanski, Self-organizing neural networks for pharmacophore mapping, Adv. Drug. Deliver. Rev. 55 (2003), pp. 1149–1162.
   PubMed Web of Science ®Google Scholar
• J. Polanski, R. Gieleciak, and A. Bak, Probability issues in molecular design: Predictive and modeling ability in 3D-QSAR schemes, Comb. Chem. High Throughput Screen. 7 (2004), pp. 793–807.
   PubMed Web of Science ®Google Scholar
• A. Bak and J. Polanski, A 4D-QSAR study on anti-HIV HEPT analogues, Bioorg. Med. Chem. 14 (2006), pp. 273–279.
   PubMed Web of Science ®Google Scholar
• D.T. Stanton, QSAR and QSPR model interpretation using partial least squares (PLS) analysis, Curr. Comput. Aided Drug Des. 8 (2012), pp. 107–127.
   PubMed Web of Science ®Google Scholar
• A. Doweyko, 3D-QSAR illusions, J. Comput.-Aided Mol. Des. 18 (2004), pp. 587–596.
   PubMed Web of Science ®Google Scholar
• A. Bak and J. Polanski, Modeling robust QSAR 3: SOM-4D-QSAR with iterative variable elimination IVE-PLS: Application to steroid, azo dye, and benzoic acid series, J. Chem. Inf. Model. 47 (2007), pp. 1469–1480.
   PubMed Web of Science ®Google Scholar
• V. Centner, D.L. Massart, O.E. de Noord, S. de Jong, B.M.V. Vandeginste, and C. Sterna, Elimination of uninformative variables for multivariate calibration, Anal. Chem. 68 (1996), pp. 3851–3858.
   PubMed Web of Science ®Google Scholar
• M. Fialkowski, K.J.M. Bishop, V.A. Chubukov, C.J. Campbell, and B.A. Grzybowski, Architecture and evolution of organic chemistry, Angew. Chem. Int. Ed. 44 (2005), pp. 7263–7269.
   PubMed Web of Science ®Google Scholar
• J. Polanski and J. Gasteiger, Computer representation of chemical compounds, in Handbook of Computational Chemistry, J. Leszczynski, and T. Puzyn, eds., Springer, Dordrecht, 2016.
   Google Scholar
• M.M. Hann and G.M. Keserü, Finding the sweet spot: The role of nature and nurture in medicinal chemistry, Nat. Rev. Drug Discov. 11 (2012), pp. 355–365.
   PubMed Web of Science ®Google Scholar
• A. Smolinski, L. Drobek, V. Dombek, and A. Bak, Modeling of experimental data on trace elements and organic compounds content in industrial waste dumps, Chemosphere 162 (2016), pp. 189–198.
   PubMed Web of Science ®Google Scholar
• I. Malik, E. Sedlarova, J. Csollei, E. Racanska, J. Cizmarik, and P. Kurfurst, Synthesis, physicochemical properties and biological activity of 1-(4-fluorophenyl)-4-[3-(2-, 3- and 4-alkyloxyphenylcarbamoyloxy)-2-hydroxypropyl]piperazinium chlorides, Sci. Pharm. 72 (2004), pp. 283–291.
   Google Scholar
• I. Malik, E. Sedlarova, J. Csollei, F. Andriamainty, P. Kurfurst, and J. Vanco, Synthesis, spectral description, and lipophilicity parameters determination of phenylcarbamic acid derivatives with integrated N-phenylpiperazine moiety in the structure, Chem. Pap. 60 (2006), pp. 42–47.
   Web of Science ®Google Scholar
• I. Malik, M. Lukac, J. Galba, and J. Stolarikova, Synthesis and in vitro antimycobacterial investigation of 2-/3-alkoxyphenylcarbamic acid derivatives containing 4′-(pyrimidin-2′]-yl)piperazin-1′]-yl moiety, Fresen. Environ. Bull. 25 (2016), pp. 2052–2062.
   Web of Science ®Google Scholar
• I. Malik, J. Curillova, J. Csollei, J. Jampilek, I. Zadrazilova, R. Govender, J. O’Mahony, A. Coffey, and P. Mikus, The synthesis and in vitro screening of the 2-/3-alkoxyphenylcarbamic acid derivatives containing a 4′-(2′]-fluorophenyl)piperazin-1′]-moiety against some non-tuberculous mycobacterial strains, Fresen. Environ. Bull. 26 (2017), pp. 2760–2771.
   Web of Science ®Google Scholar
• P. Marvanova, T. Padrtova, T. Pekarek, J. Brus, J. Czernek, P. Mokry, O. Humpa, M. Oravec, and J. Jampilek, Synthesis and characterization of new 3-(4-arylpiperazin-1-yl)-2-hydroxypropyl 4-propoxybenzoates and their hydrochloride salts, Molecules 21 (2016), pp. 707–720.
   Web of Science ®Google Scholar
• K. Waisser, R. Dolezal, J. Cizmarik, I. Malik, and J. Kaustova, The potential antituberculotics of the series of 2-hydroxy-3-(4-phenylpiperazin-1-yl)-propylphenylcarbamates, Folia Pharm. Univ. Carol. 35 (2007), pp. 45–48.
   Google Scholar
• A. Tropsha, Best practices for QSAR model development, validation and exploitation, Mol. Inf. 29 (2010), pp. 476–488.
   PubMed Web of Science ®Google Scholar
• N. Chirico and P. Gramatica, Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient, J. Chem. Inf. Model. 51 (2011), pp. 2320–2335.
   PubMed Web of Science ®Google Scholar
• A. Golbraikh and A. Tropsha, Beware of q2! J. Mol. Graph. Model. 20 (2002), pp. 269–276.
   PubMed Web of Science ®Google Scholar
• D.L.J. Alexander, A. Tropsha, and D.A.Winkler, Beware of R2: Simple, unambiguous assessment of the prediction accuracy of QSAR and QSPR models, J. Chem. Inf. Model. 55 (2015), pp. 1316–1322.
   PubMed Web of Science ®Google Scholar
• K. Roy, R.N. Das, P. Ambure, and R.B. Aher, Be aware of error measures. Further studies on validation of predictive QSAR models, Chemom. Intell. Lab. 152 (2016), pp. 18–33.
   Web of Science ®Google Scholar
• J. Polanski, A. Kurczyk, A. Bak, and R. Musiol, Privileged structures – Dream or reality: Preferential organization of azanaphthalene scaffold, Curr. Med. Chem. 19 (2012), pp. 1921–1945.
   PubMed Web of Science ®Google Scholar
• R.A. Johnson and D.W. Wichern, Applied Multivariate Statistical Analysis, 6th ed., Prentice Hall, Englewood Cliffs, New Jersey, 2006.
   Google Scholar
• M.P. Gonzalez, C. Teran, L. Saiz-Urra, and M. Teijeira, Variable selection methods in QSAR: An overview, Curr. Top. Med. Chem. 18 (2008), pp. 1606–1627.
   Google Scholar
• H. Pizova, M. Havelkova, S. Stepankova, A. Bak, T. Kauerova, V. Kozik, M. Oravec, A. Imramovsky, P. Kollar, P. Bobal, and J. Jampilek, Proline-based carbamates as cholinesterase inhibitors, Molecules 14 (2017), pp. 1969–1995.
   Google Scholar